Characteristics of the NMDA receptor modulating hypoxia/hypoglycaemia-induced rat striatal dopamine release in vitro
- 1 December 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 340 (2-3) , 133-143
- https://doi.org/10.1016/s0014-2999(97)01422-2
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitroEuropean Journal of Pharmacology, 1996
- Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomesNeurochemistry International, 1994
- Dextromethorphan Inhibits Ischemia-induced c-fos Expression and Delayed Neuronal Death in Hippocampal NeuronsAnesthesiology, 1994
- Structural requirements for the development of potent acid (NMDA) receptor antagonistsBiochemical Pharmacology, 1993
- Striatal Protection Induced by Lesioning the Substantia Nigra of Rats Subjected to Focal IschemiaJournal of Neurochemistry, 1992
- Ischemia in the dorsal hippocampus is associated with acute extracellular release of dopamine and norepinephrineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Selective modulation of NMDA responses by reduction and oxidationNeuron, 1989
- Dextromethorphan and dextrorphan as calcium channel antagonistsBrain Research, 1988
- Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokes.Stroke, 1987
- Carbon fibre microelectrodesJournal of Neuroscience Methods, 1979